Canada Medical Devices Views

Pages

Galderma replies to Pligalis CRL

Galderma has responded to the FDA complete response letter (CRL) for Pliaglis (lidocaine and tetracaine cream 7%/7%). The company has licensed worldwide marketing rights for Pliaglis from Nuvo...

Read article ›

Pages

Filter results

By Geography

By Sector

By Information Type